Log in to save to my catalogue

Single-cell-led drug repurposing for Alzheimer’s disease

Single-cell-led drug repurposing for Alzheimer’s disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_782197ecf79140258cdbfbd1725f622f

Single-cell-led drug repurposing for Alzheimer’s disease

About this item

Full title

Single-cell-led drug repurposing for Alzheimer’s disease

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2023-01, Vol.13 (1), p.222-222, Article 222

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Alzheimer’s disease is the most common form of dementia. Notwithstanding the huge investments in drug development, only one disease-modifying treatment has been recently approved. Here we present a single-cell-led systems biology pipeline for the identification of drug repurposing candidates. Using single-cell RNA sequencing data of brain tissues f...

Alternative Titles

Full title

Single-cell-led drug repurposing for Alzheimer’s disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_782197ecf79140258cdbfbd1725f622f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_782197ecf79140258cdbfbd1725f622f

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-023-27420-x

How to access this item